Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients with hepatitis C virus genotype 4

被引:0
|
作者
Shiha, Gamal [1 ,2 ]
Samir, Waleed [2 ]
Seif, Seham [1 ]
El-Etreby, Shahira A. [1 ]
Abdel-Khalek, Ehab [1 ]
机构
[1] Almansoura Univ Hosp, Dept Internal Med, Mansoura, Egypt
[2] ELRIAH, Mansoura, Egypt
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1779
引用
收藏
页码:1023A / 1023A
页数:1
相关论文
共 50 条
  • [21] IMPORTANCE OF HOST GENETIC FACTOR, HLA AND IL28B, AS PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
    Munoz de Rueda, Paloma
    Lopez-Nevot, MAngel
    Saenz Lopez, Pablo
    Casado, Jorge
    Maria Martin-Casares, Antonia
    Palomares, Pablo
    Quiles, Rosa
    Gila, Ana
    Romero-Gomez, Manuel
    Jose Pavon, Esther
    Munoz-Gámez, Jose Antonio
    Carazo, Angel
    Sanz-Cameno, Paloma
    Moreno-Otero, Ricardo
    Diago, Moises
    Palacios, Angel
    Ruiz-Extremera, Angeles
    Salmeron, Javier
    HEPATOLOGY, 2010, 52 (04) : 786A - 786A
  • [22] Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
    Kurosaki, Masayuki
    Tanaka, Yasuhito
    Nishida, Nao
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Honda, Masao
    Sugiyama, Masaya
    Matsuura, Kentaro
    Sugauchi, Fuminaka
    Asahina, Yasuhiro
    Nakagawa, Mina
    Watanabe, Mamoru
    Sakamoto, Minoru
    Maekawa, Shinya
    Sakai, Akito
    Kaneko, Shuichi
    Ito, Kiyoaki
    Masaki, Naohiko
    Tokunaga, Katsushi
    Izumi, Namiki
    Mizokami, Masashi
    JOURNAL OF HEPATOLOGY, 2011, 54 (03) : 439 - 448
  • [23] Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C genotype 4 patients
    Khattab, Mahmoud A.
    Abdelghany, Hend M.
    Ramzy, Maggie M.
    Khairy, Rasha M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2016, 30 (01): : 40 - 45
  • [24] Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin
    McCarthy, Jeanette J.
    Li, Josephine H.
    Thompson, Alexander
    Suchindran, Sunil
    Lao, Xiang Qian
    Patel, Keyur
    Tillmann, Hans L.
    Muir, Andrew J.
    McHutchison, John G.
    GASTROENTEROLOGY, 2010, 138 (07) : 2307 - 2314
  • [25] Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin
    Lyoo, KwangSoo
    Song, Myeong Jun
    Hur, Wonhee
    Choi, Jung Eun
    Hong, Sung Woo
    Kim, Chang Wook
    Bae, Si Hyun
    Choi, Jong Young
    Choi, Sang Wook
    Shin, Eui-Cheol
    Yoon, Seung Kew
    JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (04) : 363 - 366
  • [26] Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Kondo, Chisa
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Kobayashi, Tamaki
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Kanazawa, Hidenori
    Iwakiri, Katsuhiko
    Sakamoto, Choitsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 443 - 449
  • [27] VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Doi, Yoshinori
    Ogawa, Hiroyuki
    Hagiwara, Hideki
    Mita, Eiji
    Kaneko, Akira
    Katayama, Kazuhiro
    Hijioka, Taizo
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Hayashi, Eijirou
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2011, 54 : 852A - 853A
  • [28] Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
    Yasuhito Tanaka
    Nao Nishida
    Masaya Sugiyama
    Masayuki Kurosaki
    Kentaro Matsuura
    Naoya Sakamoto
    Mina Nakagawa
    Masaaki Korenaga
    Keisuke Hino
    Shuhei Hige
    Yoshito Ito
    Eiji Mita
    Eiji Tanaka
    Satoshi Mochida
    Yoshikazu Murawaki
    Masao Honda
    Akito Sakai
    Yoichi Hiasa
    Shuhei Nishiguchi
    Asako Koike
    Isao Sakaida
    Masatoshi Imamura
    Kiyoaki Ito
    Koji Yano
    Naohiko Masaki
    Fuminaka Sugauchi
    Namiki Izumi
    Katsushi Tokunaga
    Masashi Mizokami
    Nature Genetics, 2009, 41 : 1105 - 1109
  • [29] Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
    Tanaka, Yasuhito
    Nishida, Nao
    Sugiyama, Masaya
    Kurosaki, Masayuki
    Matsuura, Kentaro
    Sakamoto, Naoya
    Nakagawa, Mina
    Korenaga, Masaaki
    Hino, Keisuke
    Hige, Shuhei
    Ito, Yoshito
    Mita, Eiji
    Tanaka, Eiji
    Mochida, Satoshi
    Murawaki, Yoshikazu
    Honda, Masao
    Sakai, Akito
    Hiasa, Yoichi
    Nishiguchi, Shuhei
    Koike, Asako
    Sakaida, Isao
    Imamura, Masatoshi
    Ito, Kiyoaki
    Yano, Koji
    Masaki, Naohiko
    Sugauchi, Fuminaka
    Izumi, Namiki
    Tokunaga, Katsushi
    Mizokami, Masashi
    NATURE GENETICS, 2009, 41 (10) : 1105 - U81
  • [30] Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4
    Rivero-Juarez, Antonio
    Camacho Espejo, Angela
    Perez-Camacho, Ines
    Neukam, Karin
    Caruz, Antonio
    Antonio Mira, Jose
    Mesa, Pilar
    Garcia-Lazaro, Milagros
    Torre-Cisneros, Julian
    Antonio Pineda, Juan
    Rivero, Antonio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 202 - 205